Skip to main content
logo
Epitomee Medical Ltd (TLV:EPIT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
284.40
-3.50 (-1.22%)
Aug 24, 2026, 12:14 PM IDT

Epitomee Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.780.21-10--
Revenue Growth
------
Cost of Revenue
2.040.87----
Gross Profit
-1.26-0.65-10--
Selling, General & Admin
3.523.483.442.793.282.6
Research & Development
4.825.45.546.87.796.18
Other Operating Expenses
---6.977.18--
Operating Expenses
8.348.88216.7611.078.77
Operating Income
-9.6-9.53-2-6.76-11.07-8.77
Interest Expense
-1.22-0.85-0.19-0.06--2.71
Interest & Investment Income
0.680.681.21.60.480.07
Currency Exchange Gain (Loss)
1.11.1-0.46-0.46-4.9-0.1
Other Non Operating Income (Expenses)
-0.83-0.01-0.01-0.010.1-
Pretax Income
-9.88-8.61-1.46-5.68-15.39-11.52
Net Income
-9.88-8.61-1.46-5.68-15.39-11.52
Net Income to Common
-9.88-8.61-1.46-5.68-15.39-11.52
Net Income Growth
------
Shares Outstanding (Basic)
30303030292
Shares Outstanding (Diluted)
30303030292
Shares Change
1.40%0.97%0.36%0.69%1575.26%669.53%
EPS (Basic)
-0.33-0.29-0.05-0.19-0.52-6.55
EPS (Diluted)
-0.33-0.29-0.05-0.19-0.52-6.55
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-9.69-9.49-12.91-12-13.12-6.16
Free Cash Flow Per Share
-0.32-0.32-0.43-0.40-0.45-3.50
Gross Margin
-162.47%--100.00%--
Operating Margin
-1233.93%-4475.12%--67.63%--
Profit Margin
-1269.28%-4043.19%--56.82%--
Free Cash Flow Margin
-1245.50%-4455.87%--119.96%--
EBITDA
-8.9-9.03-1.99-6.55-11.01-8.72
EBITDA Margin
----65.49%--
D&A For EBITDA
0.70.50.020.210.060.05
EBIT
-9.6-9.53-2-6.76-11.07-8.77
EBIT Margin
----67.63%--